Health ❯ Healthcare ❯ Research
Phase 3 Trials Efficacy Studies Trial Results Trial Outcomes Cancer Research AI in Medicine Trial Methodology Gene Therapy Trials Innovative Therapies Phase 2 Trials
The result suggests a drug that blocks the immune protein IL‑15 could become the first therapy to protect celiac patients from accidental gluten exposure and will move into larger trials.